Neuromodulation Market Growth Analysis and 2021 Forecasts Report Neuromodulation Market Research Report and Trends | Page 2

Neuromodulation Market - Global Industry Analysis, Size, Share, Growth,
Trends and Forecasts – 2021
Global Neuromodulation Market is poised to cross US$ 5 Billion mark by 2021. Neuromodulation is a
technology that acts directly upon nerves. It is the alteration-or modulation-of nerve activity by delivering
electrical or pharmaceutical agents directly to a target area. Neuromodulation devices and treatments are
life changing. They affect every area of the body and treat nearly every disease or symptom from
headaches to tremors to spinal cord damage to urinary incontinence. With such a broad therapeutic scope,
and significant ongoing improvements in biotechnology, the neuromodulation is poised as a major growth
industry for the next decade.
Company Coverage of Global Neuromodulation Market: Medtronic, Boston Scientific, St. Jude Medical,
LivaNova (Cyberonics), Nevro Corp, Others.
By Technology Neuromodulation Market Analysis:
In terms of technology, Spinal cord stimulation (SCS) is the largest segment of the market and is mostly
indicated for treatment of chronic pain. Deep brain stimulation (DBS) represents the second largest
segment within the neuromodulation market being followed by Sacral nerve stimulation (SNS) at the third
spot in 2015. The VNS segment stands at the fourth spot with around XX% share of the neuromodulation
market in 2015.
The market growth is attributed to factors such as an increased adoption of neuromodulation devices,
ageing population, rising prevalence of diseases relevant to neuromodulation, technological advancements
and deal making activity globally.
Complete report available at http://www.marketreportsonline.com/563956.html